FB
Florey Biosciences engineers precision probiotics using synthetic biology to address human health challenges. The company develops science-backed solutions, such as FLR-101, an engineered probiotic medical food designed to manage gut microbiome perturbations caused by antibiotics. This work aims to support the continued efficacy of antibiotics by restoring microbial balance.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Florey Biosciences engineers precision probiotics using synthetic biology to mitigate the adverse effects of antibiotics on the gut microbiome. Their lead product, FLR-101, is a medical food designed to restore microbial balance disrupted by antibiotic use, enhancing digestive and immune health.